Citations (129)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Nawaf A. Alsaif, Mohammed S. Taghour, Mohammed M. Alanazi, Ahmad J. Obaidullah, Abdulrahman A. Al-Mehizia, Manal M. Alanazi, Saleh Aldawas, Alaa Elwan & Hazem Elkady. (2021) Discovery of new VEGFR-2 inhibitors based on bis([1, 2, 4]triazolo)[4,3-a:3',4'-c]quinoxaline derivatives as anticancer agents and apoptosis inducers. Journal of Enzyme Inhibition and Medicinal Chemistry 36:1, pages 1093-1114.
Read now
Read now
Di Zhang, Jiaqi Huang, Yulan Sun & Qisen Guo. (2019) Long-term progression-free survival of apatinib monotherapy for relapsed ovarian cancer: a case report and literature review. OncoTargets and Therapy 12, pages 3635-3644.
Read now
Read now
Zhihong Dong, Chunxia Yu, Kuerban Rezhiya, Aier Gulijiahan & Xinling Wang. (2019) Downregulation of miR-146a promotes tumorigenesis of cervical cancer stem cells via VEGF/CDC42/PAK1 signaling pathway. Artificial Cells, Nanomedicine, and Biotechnology 47:1, pages 3711-3719.
Read now
Read now
Laura Kuhlmann, Emma Cummins, Ismael Samudio & Thomas Kislinger. (2018) Cell-surface proteomics for the identification of novel therapeutic targets in cancer. Expert Review of Proteomics 15:3, pages 259-275.
Read now
Read now
Nonkululeko N Mthembu, Zukile Mbita, Rodney Hull & Zodwa Dlamini. (2017) Abnormalities in alternative splicing of angiogenesis-related genes and their role in HIV-related cancers. HIV/AIDS - Research and Palliative Care 9, pages 77-93.
Read now
Read now
Ana P. S. Silva, Priscila V. Coelho, Maristella Anazetti & Patricia U. Simioni. (2017) Targeted therapies for the treatment of non-small-cell lung cancer: Monoclonal antibodies and biological inhibitors. Human Vaccines & Immunotherapeutics 13:4, pages 843-853.
Read now
Read now
Yang Shen, Lin Zeng, Ruslan Novosyadlyy, Amelie Forest, Aiping Zhu, Andrew Korytko, Haifan Zhang, Scott W Eastman, Michael Topper, Sagit Hindi, Nicole Covino, Kris Persaud, Yun Kang, Douglas Burtrum, David Surguladze, Marie Prewett, Sudhakar Chintharlapalli, Victor J Wroblewski, Juqun Shen, Paul Balderes, Zhenping Zhu, Marshall Snavely & Dale L Ludwig. (2015) A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation. mAbs 7:5, pages 931-945.
Read now
Read now
Rima Ait-Belkacem, Caroline Berenguer, Claude Villard, L’Houcine Ouafik, Dominique Figarella-Branger, Alain Beck, Olivier Chinot & Daniel Lafitte. (2014) Monitoring therapeutic monoclonal antibodies in brain tumor. mAbs 6:6, pages 1385-1393.
Read now
Read now
Articles from other publishers (121)
Julieta Griselda Mendoza-Torreblanca, Noemi Cárdenas-Rodríguez, Jazmín Carro-Rodríguez, Itzel Jatziri Contreras-García, David Garciadiego-Cázares, Daniel Ortega-Cuellar, Valentín Martínez-López, Alfonso Alfaro-Rodríguez, Alberto Nayib Evia-Ramírez, Iván Ignacio-Mejía, Marco Antonio Vargas-Hernández & Cindy Bandala. (2023) Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis. International Journal of Molecular Sciences 24:12, pages 10199.
Crossref
Crossref
Yuxuan Zhao, Songhang Li, Maogeng Feng, Mei Zhang, Zhiqiang Liu, Yangxue Yao, Tianxu Zhang, Yueying Jiang, Yunfeng Lin & Xiaoxiao Cai. (2023) Effects of Puerarin‐Loaded Tetrahedral Framework Nucleic Acids on Osteonecrosis of the Femoral Head. Small.
Crossref
Crossref
Wattana Leowattana, Tawithep Leowattana & PathompThep Leowattana. (2023) Systemic treatment for unresectable hepatocellular carcinoma. World Journal of Gastroenterology 29:10, pages 1551-1568.
Crossref
Crossref
Wattana Leowattana, Tawithep Leowattana & PathompThep Leowattana. (2023) Systemic treatment for unresectable hepatocellular carcinoma. World Journal of Gastroenterology 29:10, pages 1407-1424.
Crossref
Crossref
Hardeep Singh Tuli, Vivek K. Garg, Renuka Choudhary, Ashif Iqubal, Katrin Sak, Adesh K. Saini, Reena V. Saini, Kanupriya Vashishth, Kuldeep Dhama, Ranjan K. Mohapatra, Dhruv Sanjay Gupta & Ginpreet Kaur. (2022) Immunotherapeutics in lung cancers: from mechanistic insight to clinical implications and synergistic perspectives. Molecular Biology Reports 50:3, pages 2685-2700.
Crossref
Crossref
Yuki Wakayama & Satoru Yamagishi. (2023) Vascular and Neuronal Network Formation Regulated by Growth Factors and Guidance Cues. Life 13:2, pages 283.
Crossref
Crossref
Madeline MacDonald, Darin Poei, Alexis Leyba, Raymond Diep, Krithika Chennapan, Christopher Leon, Bing Xia, Jorge J. Nieva & Robert Hsu. (2023) Real world prognostic utility of platelet lymphocyte ratio and nutritional status in first-line immunotherapy response in stage IV non-small cell lung cancer. Cancer Treatment and Research Communications 36, pages 100752.
Crossref
Crossref
Laura Torres-Canchala, Daniela Cleves-Luna, Oriana Arias-Valderrama, Estephania Candelo, María Angelica Guerra, Harry Pachajoa & Manuela Olaya. (2022) Systemic Bevacizumab for Recurrent Respiratory Papillomatosis: A Scoping Review from 2009 to 2022. Children 10:1, pages 54.
Crossref
Crossref
Ajmal Ahmad & Mohd Imtiaz Nawaz. (2022) Molecular mechanism of VEGF and its role in pathological angiogenesis. Journal of Cellular Biochemistry 123:12, pages 1938-1965.
Crossref
Crossref
Ryan Ruiz, Naomi BalamuthLuv R. JaviaKaren B. Zur. (2022)
Systemic Bevacizumab Treatment for Recurrent Respiratory Papillomatosis: Long‐Term
Follow‐Up
. The Laryngoscope 132:10, pages 2071-2075.
Crossref
Crossref
Yuanfei Shi, Jing Ye, Huafei Shen, Yi Xu, Rui Wan, Xiujin Ye, Jie Jin & Wanzhuo Xie. (2022)
Apatinib enhances chemosensitivity of
ABT
‐199 in diffuse large B‐cell lymphoma
. Molecular Oncology 16:20, pages 3735-3753.
Crossref
Crossref
Lingfeng Yu, Hao Zhu, Zhen Wang, Jianhao Huang, Yan Zhu, Gentao Fan, Yicun Wang, Xi Chen & Guangxin Zhou. (2022) Circular RNA circFIRRE drives osteosarcoma progression and metastasis through tumorigenic-angiogenic coupling. Molecular Cancer 21:1.
Crossref
Crossref
Layla Simón, Sofía Sanhueza, Belén Gaete-Ramírez, Manuel Varas-Godoy & Andrew F. G. Quest. (2022) Role of the Pro-Inflammatory Tumor Microenvironment in Extracellular Vesicle-Mediated Transfer of Therapy Resistance. Frontiers in Oncology 12.
Crossref
Crossref
Juan Tang, Youling Gong & Xuelei Ma. (2022) Bispecific Antibodies Progression in Malignant Melanoma. Frontiers in Pharmacology 13.
Crossref
Crossref
Ying Han, Ziyu Zhu & Qi You. (2022) The Survival Relationship between Preoperative Inflammation Markers and Patients with Special Pathological Types of Gastric Cancer. Canadian Journal of Gastroenterology and Hepatology 2022, pages 1-10.
Crossref
Crossref
Lucia Morbidelli & Sandra Donnini. 2022. Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy. Antiangiogenic Drugs as Chemosensitizers in Cancer Therapy
1
28
.
Kuo Zhang, Hui Zhang, Yong-Hong Gao, Jia-Qi Wang, Yuan Li, Hui Cao, Ying Hu & Lei Wang. (2021) A Monotargeting Peptidic Network Antibody Inhibits More Receptors for Anti-Angiogenesis. ACS Nano 15:8, pages 13065-13076.
Crossref
Crossref
Ángela Alonso-Diez, Sara Cáceres, Laura Peña, Belén Crespo & Juan Carlos Illera. (2021) Anti-Angiogenic Treatments Interact with Steroid Secretion in Inflammatory Breast Cancer Triple Negative Cell Lines. Cancers 13:15, pages 3668.
Crossref
Crossref
Hitesh Verma, Ashwin Chandran, Pirabu Shaktivel, Archana Singh, Seema Kaushal, Kapil Sikka, Alok Thakar & D.V.K. Irugu. (2021) The serum and tissue expression of vascular endothelial growth factor-in recurrent respiratory papillomatosis. International Journal of Pediatric Otorhinolaryngology 146, pages 110737.
Crossref
Crossref
Minting Liu, Caisheng Wu, Lingjie Ke, Zhiguo Li & Yun‐Long Wu. (2021) Emerging Biomaterials‐Based Strategies for Inhibiting Vasculature Function in Cancer Therapy. Small Methods 5:7.
Crossref
Crossref
Ziyu Zhu, Jialiang Gao, Zhixin Liu, Chunfeng Li & Yingwei Xue. (2021) Preoperative Platelet-to-Lymphocyte Ratio (PLR) for Predicting the Survival of Stage I-III Gastric Cancer Patients with a MGC Component. BioMed Research International 2021, pages 1-10.
Crossref
Crossref
Abdallah E. Abdallah, Sally I. Eissa, Maged Mohammed Saleh Al Ward, Reda R. Mabrouk, Ahmed B.M. Mehany & Mohamed Ayman El-Zahabi. (2021) Design, synthesis and molecular modeling of new quinazolin-4(3H)-one based VEGFR-2 kinase inhibitors for potential anticancer evaluation. Bioorganic Chemistry 109, pages 104695.
Crossref
Crossref
Ryan Ruiz & Karen B. Zur. (2021) Recurrent Respiratory Papillomatosis. Current Otorhinolaryngology Reports 9:1, pages 23-28.
Crossref
Crossref
Suresh Madheswaran, Neelakshi Mungra, Fleury A.N. Biteghe, Jean De la Croix Ndong, Afolake T. Arowolo, Henry A. Adeola, Dharanidharan Ramamurthy, Krupa Naran, Nonhlanhla P. Khumalo & Stefan Barth. (2020) Antibody-Based Targeted Interventions for the Diagnosis and Treatment of Skin Cancers. Anti-Cancer Agents in Medicinal Chemistry 21:2, pages 162-186.
Crossref
Crossref
N. García-Romero, I. Palacín-Aliana, R. Madurga, J. Carrión-Navarro, S. Esteban-Rubio, B. Jiménez, A. Collazo, F. Pérez-Rodríguez, A. Ortiz de Mendivil, C. Fernández-Carballal, S. García-Duque, J. Diamantopoulos-Fernández, C. Belda-Iniesta, R. Prat-Acín, P. Sánchez-Gómez, E. Calvo & A. Ayuso-Sacido. (2020) Bevacizumab dose adjustment to improve clinical outcomes of glioblastoma. BMC Medicine 18:1.
Crossref
Crossref
Giovanna Li Petri, Virginia Spanò, Roberto Spatola, Ralph Holl, Maria Valeria Raimondi, Paola Barraja & Alessandra Montalbano. (2020) Bioactive pyrrole-based compounds with target selectivity. European Journal of Medicinal Chemistry 208, pages 112783.
Crossref
Crossref
Weilin Chen, Yulin Xie, Man Wang & Chunxia Li. (2020) Recent Advances on Rare Earth Upconversion Nanomaterials for Combined Tumor Near-Infrared Photoimmunotherapy. Frontiers in Chemistry 8.
Crossref
Crossref
Stephen P. Hack, Andrew X. Zhu & Yulei Wang. (2020) Augmenting Anticancer Immunity Through Combined Targeting of Angiogenic and PD-1/PD-L1 Pathways: Challenges and Opportunities. Frontiers in Immunology 11.
Crossref
Crossref
Misty M. Attwood, Jörgen Jonsson, Mathias Rask-Andersen & Helgi B. Schiöth. (2020) Soluble ligands as drug targets. Nature Reviews Drug Discovery 19:10, pages 695-710.
Crossref
Crossref
Lianghao Zhang, Longqing LiJunxiao Liu, Jiange Wang, Yafeng Fan, Biao Dong, Zhaowei Zhu & Xuepei Zhang. (2020) Meta-analysis of multiple hematological biomarkers as prognostic predictors of survival in bladder cancer. Medicine 99:30, pages e20920.
Crossref
Crossref
Kuo Zhang, Pei-Pei Yang, Ping-Ping He, Shi-Fang Wen, Xiao-Ran Zou, Yu Fan, Zi-Ming Chen, Hui Cao, Zhou Yang, Kai Yue, Xinxin Zhang, Hua Zhang, Lei Wang & Hao Wang. (2020) Peptide-Based Nanoparticles Mimic Fibrillogenesis of Laminin in Tumor Vessels for Precise Embolization. ACS Nano 14:6, pages 7170-7180.
Crossref
Crossref
Long-Qing Li, Zhen-Hua Bai, Liang-Hao Zhang, Yan Zhang, Xin-Chang Lu, Yi Zhang, Yong-Kui Liu, Jia Wen & Jia-Zhen Li. (2020) Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis. Frontiers in Oncology 10.
Crossref
Crossref
Chia-Jui Yen, Masatoshi Kudo, Ho-Yeong Lim, Chih-Hung Hsu, Arndt Vogel, Giovanni Brandi, Rebecca Cheng, Ioana Simona Nitu, Paolo Abada, Yanzhi Hsu, Andrew X. Zhu & Yoon-Koo Kang. (2020) Efficacy and Safety of Ramucirumab in Asian and Non-Asian Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha-Fetoprotein: Pooled Individual Data Analysis of Two Randomized Studies. Liver Cancer 9:4, pages 440-454.
Crossref
Crossref
Jacek R. Wilczyński, Marek Nowak & Miłosz Wilczyński. 2020. Cancer Immunology. Cancer Immunology
487
540
.
Bruno António Cardoso. 2020. Tumor Microenvironment. Tumor Microenvironment
259
293
.
Prachi Rana, John Haydek & Anjana Pillai. (2019) The Current Landscape of Systemic Therapies for Advanced Hepatocellular Carcinoma. Current Hepatology Reports 18:4, pages 371-382.
Crossref
Crossref
Jian Hua Qi, Brent Bell, Rupesh Singh, Julia Batoki, Alyson Wolk, Alecia Cutler, Nicholas Prayson, Mariya Ali, Heidi Stoehr & Bela Anand-Apte. (2019) Sorsby Fundus Dystrophy Mutation in Tissue Inhibitor of Metalloproteinase 3 (TIMP3) promotes Choroidal Neovascularization via a Fibroblast Growth Factor-dependent Mechanism. Scientific Reports 9:1.
Crossref
Crossref
Milene Dalmina, Frederico Pittella, Jelver Alexander Sierra, Gabriela Regina Rosa Souza, Adny Henrique Silva, André Avelino Pasa & Tânia Beatriz Creczynski-Pasa. (2019) Magnetically responsive hybrid nanoparticles for in vitro siRNA delivery to breast cancer cells. Materials Science and Engineering: C 99, pages 1182-1190.
Crossref
Crossref
Masoud Alasvand, Vahideh Assadollahi, Roberto Ambra, Ehsan Hedayati, Wesam Kooti & Ilaria Peluso. (2019) Antiangiogenic Effect of Alkaloids. Oxidative Medicine and Cellular Longevity 2019, pages 1-16.
Crossref
Crossref
Yudi Han, Jing Ren, Yun Bai, Xuetao Pei & Yan Han. (2019) Exosomes from hypoxia-treated human adipose-derived mesenchymal stem cells enhance angiogenesis through VEGF/VEGF-R. The International Journal of Biochemistry & Cell Biology 109, pages 59-68.
Crossref
Crossref
Claudio Carnevale, Luis Ferrán‐De la Cierva, Guillermo Til‐Pérez, José Antonio Peña‐Zarza, Borja Osona‐Rodriguez, Joaquina Martinez‐Lozano, Pedro Sarría‐Echegaray, Diego Arancibia‐Tagle & Manuel Tomás‐Barberán. (2018) Safe use of systemic bevacizumab for respiratory recurrent papillomatosis in two children. The Laryngoscope 129:4, pages 1001-1004.
Crossref
Crossref
Yan Wang, Manman Deng, Qinwei Chen, Yin Li, Xutao Guo, Pengcheng Shi, Lingli He, Siting Xie, Lian Yu, Haiping Zhang & Bing Xu. (2019) Apatinib exerts anti-tumor activity to non-Hodgkin lymphoma by inhibition of the Ras pathway. European Journal of Pharmacology 843, pages 145-153.
Crossref
Crossref
Mayte Delgado-Ureña, Francisco G. Ortega, Diego de Miguel-Pérez, Alba Rodriguez-Martínez, Jose L. García-Puche, Hugh Ilyine, Jose A. Lorente, Jose Exposito-Hernandez, M. Carmen Garrido-Navas, Miguel Delgado-Ramirez & M. José Serrano. (2018) Circulating tumor cells criteria (CyCAR) versus standard RECIST criteria for treatment response assessment in metastatic colorectal cancer patients. Journal of Translational Medicine 16:1.
Crossref
Crossref
Di Zhang, Chufeng Zhang, Jiaqi Huang, Yan Guan & Qisen Guo. (2018) Clinical investigation of the efficacy and toxicity of apatinib (YN968D1) in stage III/IV non‐small cell lung cancer after second‐line chemotherapy treatment: A retrospective study. Thoracic Cancer 9:12, pages 1754-1762.
Crossref
Crossref
Bushra Husain & Diego Ellerman. (2018) Expanding the Boundaries of Biotherapeutics with Bispecific Antibodies. BioDrugs 32:5, pages 441-464.
Crossref
Crossref
Muhammad Abbas, Alessia Faggian, Dahiru Nasiru Sintali, Ghulam Jilany Khan, Shagufta Naeem, Meiqi Shi & Chen Dingding. (2018) Current and future biomarkers in gastric cancer. Biomedicine & Pharmacotherapy 103, pages 1688-1700.
Crossref
Crossref
Zhun Wang, Shuanghe Peng, Aixiang Wang, Hui Xie, Linpei Guo, Ning Jiang & Yuanjie Niu. (2018) Platelet-lymphocyte ratio acts as an independent predictor of prognosis in patients with renal cell carcinoma. Clinica Chimica Acta 480, pages 166-172.
Crossref
Crossref
Shunsuke Shibao, Ryo Ueda, Katsuya Saito, Ryogo Kikuchi, Hideaki Nagashima, Atsuhiro Kojima, Hiroshi Kagami, Eriel Sandika Pareira, Hikaru Sasaki, Shinobu Noji, Yutaka Kawakami, Kazunari Yoshida & Masahiro Toda. (2018) A pilot study of peptide vaccines for VEGF receptor 1 and 2 in patients with recurrent/progressive high grade glioma. Oncotarget 9:30, pages 21569-21579.
Crossref
Crossref
Bryce LaFoya, Jordan Munroe, Alison Miyamoto, Michael Detweiler, Jacob Crow, Tana Gazdik & Allan Albig. (2018) Beyond the Matrix: The Many Non-ECM Ligands for Integrins. International Journal of Molecular Sciences 19:2, pages 449.
Crossref
Crossref
Daniel S. Chen & Herbert Hurwitz. (2018) Combinations of Bevacizumab With Cancer Immunotherapy. The Cancer Journal 24:4, pages 193-204.
Crossref
Crossref
Livia P. Mendes, Eliana M. Lima & Vladimir P. Torchilin. 2018. Handbook of Nanomaterials for Cancer Theranostics. Handbook of Nanomaterials for Cancer Theranostics
245
277
.
Shervin Taslimi & Sunit Das. 2018. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy. Handbook of Brain Tumor Chemotherapy, Molecular Therapeutics, and Immunotherapy
361
371
.
M. Luisa Iruela-Arispe. 2018. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
5915
5920
.
Juliet C. Gray & Paul M. Sondel. 2018. Immunotherapy for Pediatric Malignancies. Immunotherapy for Pediatric Malignancies
65
78
.
Jinqian Liang, Hong Zhao, Jianhua Hu, Yong Liu & Zheng Li. (2017) SPOCD1 promotes cell proliferation and inhibits cell apoptosis in human osteosarcoma. Molecular Medicine Reports.
Crossref
Crossref
Lisa O'Brien, Paul Westwood, Ling Gao & Michael Heathman. (2017) Population pharmacokinetic meta‐analysis of ramucirumab in cancer patients. British Journal of Clinical Pharmacology 83:12, pages 2741-2751.
Crossref
Crossref
Paul A. Moore, Ross La Motte‐Mohs, Jonathan C. Li & Gurunadh R. Chichili. 2017. Protein Therapeutics. Protein Therapeutics
521
585
.
Martin Reck, Luis Paz-Ares, Paolo Bidoli, Federico Cappuzzo, Shaker Dakhil, Denis Moro-Sibilot, Hossein Borghaei, Melissa Johnson, Robert Jotte, Nathan A. Pennell, Frances A. Shepherd, Anne Tsao, Michael Thomas, Gebra Cuyun Carter, Faye Chan-Diehl, Ekaterine Alexandris, Pablo Lee, Annamaria Zimmermann, Andreas Sashegyi & Maurice Pérol. (2017) Outcomes in patients with aggressive or refractory disease from REVEL: A randomized phase III study of docetaxel with ramucirumab or placebo for second-line treatment of stage IV non-small-cell lung cancer. Lung Cancer 112, pages 181-187.
Crossref
Crossref
Luis G. Paz-Ares, Maurice Pérol, Tudor-Eliade Ciuleanu, Ruben Dario Kowalyszyn, Martin Reck, Conrad R. Lewanski, Konstantinos Syrigos, Oscar Arrieta, Kumar Prabhash, Keunchil Park, Joanna Pikiel, Tuncay Göksel, Pablo Lee, Anna Zimmermann, Gebra Cuyun Carter, Ekaterine Alexandris & Edward B. Garon. (2017) Treatment outcomes by histology in REVEL: A randomized phase III trial of Ramucirumab plus docetaxel for advanced non-small cell lung cancer. Lung Cancer 112, pages 126-133.
Crossref
Crossref
Matthias Bartneck. (2017) Immunomodulatory Nanomedicine. Macromolecular Bioscience 17:10.
Crossref
Crossref
M Kim, K Jang, P Miller, M Picon-Ruiz, T M Yeasky, D El-Ashry & J M Slingerland. (2017) VEGFA links self-renewal and metastasis by inducing Sox2 to repress miR-452, driving Slug. Oncogene 36:36, pages 5199-5211.
Crossref
Crossref
Manar S Shafat, Bruno Gnaneswaran, Kristian M Bowles & Stuart A Rushworth. (2017) The bone marrow microenvironment – Home of the leukemic blasts. Blood Reviews 31:5, pages 277-286.
Crossref
Crossref
Patrice Debré & Francis Galibert. (2017) Immunothérapie par anticorps monoclonaux : ingénierie, indications et perspectives. Bulletin de l'Académie Nationale de Médecine 201:7-9, pages 1023-1035.
Crossref
Crossref
Matthew Goblirsch, Georg Richtig, Ondrej SlabyIoana Berindan-Neagoe, Armin Gerger & Martin Pichler. (2017) MicroRNAs as a tool to aid stratification of colorectal cancer patients and to guide therapy. Pharmacogenomics 18:10, pages 1027-1038.
Crossref
Crossref
Karen B. ZurElizabeth Fox. (2017) Bevacizumab chemotherapy for management of pulmonary and laryngotracheal papillomatosis in a child. The Laryngoscope 127:7, pages 1538-1542.
Crossref
Crossref
Patrick L Mulcrone, J Preston Campbell, Lise Clément-Demange, Ana Lia Anbinder, Alyssa R Merkel, Rolf A Brekken, Julie A Sterling & Florent Elefteriou. (2017) Skeletal Colonization by Breast Cancer Cells Is Stimulated by an Osteoblast and β2AR-Dependent Neo-Angiogenic Switch. Journal of Bone and Mineral Research 32:7, pages 1442-1454.
Crossref
Crossref
Nadine Mahfouz, Roula Tahtouh, Nada Alaaeddine, Joelle El Hajj, Riad Sarkis, Ray Hachem, Issam Raad & George Hilal. (2017) Gastrointestinal cancer cells treatment with bevacizumab activates a VEGF autoregulatory mechanism involving telomerase catalytic subunit hTERT via PI3K-AKT, HIF-1α and VEGF receptors. PLOS ONE 12:6, pages e0179202.
Crossref
Crossref
Junning Cao, Dongmei Ji, Zhiyu Chen, Weina Shen, Jin Wang, Baoyue Li, Haidong Chi, Amanda Long, Ling Gao & Jin Li. (2017) Phase I Dose-Escalation Study of Ramucirumab in Chinese Patients with Advanced Solid Tumors. The Oncologist 22:6, pages 638-e56.
Crossref
Crossref
Izabela Papiewska-Paj?k, Aneta Balcerczyk, Emilia Stec-Martyna, Wiktor Kozio?kiewicz & Joanna Boncela. (2017) Vascular endothelial growth factor-D modulates oxidant-antioxidant balance of human vascular endothelial cells. Journal of Cellular and Molecular Medicine 21:6, pages 1139-1149.
Crossref
Crossref
Alessandra Cecchini, Vittoria Raffa, Francesco Canfarotta, Giovanni Signore, Sergey Piletsky, Michael P. MacDonald & Alfred Cuschieri. (2017) In Vivo Recognition of Human Vascular Endothelial Growth Factor by Molecularly Imprinted Polymers. Nano Letters 17:4, pages 2307-2312.
Crossref
Crossref
Soad K. Salama, Magda F. Mohamed, Ahmed F. Darweesh, Ahmed H.M. Elwahy & Ismail A. Abdelhamid. (2017) Molecular docking simulation and anticancer assessment on human breast carcinoma cell line using novel bis(1,4-dihydropyrano[2,3- c ]pyrazole-5-carbonitrile) and bis(1,4-dihydropyrazolo[4′,3′:5,6]pyrano[2,3- b ]pyridine-6-carbonitrile) derivatives. Bioorganic Chemistry 71, pages 19-29.
Crossref
Crossref
Masatoshi Kudo, Etsuro Hatano, Shinichi Ohkawa, Hirofumi Fujii, Akihide Masumoto, Junji Furuse, Yoshiyuki Wada, Hiroshi Ishii, Shuntaro Obi, Shuichi Kaneko, Seiji Kawazoe, Osamu Yokosuka, Masafumi Ikeda, Katsuaki Ukai, Sojiro Morita, Akihito Tsuji, Toshihiro Kudo, Mitsuo Shimada, Yukio Osaki, Ryosuke Tateishi, Gen Sugiyama, Paolo Benjamin Abada, Ling Yang, Takuji Okusaka & Andrew Xiuxuan Zhu. (2016) Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial. Journal of Gastroenterology 52:4, pages 494-503.
Crossref
Crossref
Yanyun Zhu, Wen Si, Qiong Sun, Boyu Qin, Weihong Zhao & Junlan Yang. (2016) Platelet-lymphocyte ratio acts as an indicator of poor prognosis in patients with breast cancer. Oncotarget 8:1, pages 1023-1030.
Crossref
Crossref
E Alirahimi, A Ashkiyan, F Kazemi-Lomedasht, K Azadmanesh, M Hosseininejad-chafi, M Habibi-Anbouhi, R Moazami & M Behdani. (2016) Intrabody targeting vascular endothelial growth factor receptor-2 mediates downregulation of surface localization. Cancer Gene Therapy 24:1, pages 33-37.
Crossref
Crossref
M. Luisa Iruela-Arispe. 2017. Encyclopedia of Signaling Molecules. Encyclopedia of Signaling Molecules
1
7
.
Grace Gar-Lee Yue, Minghua Liu, Zhili Zuo, Zhili Zuo, Julia Kin-Ming Lee, Mingyue Li, Stephen Kwok-Wing Tsui, Kwok-Pui Fung, Handong Sun, Jianxin Pu & Clara Bik-San Lau. (2016) Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling. Oncotarget 7:50.
Crossref
Crossref
Joon Oh Park, Baek-Yeol Ryoo, Chia-Jui Yen, Masatoshi Kudo, Ling Yang, Paolo B. Abada, Rebecca Cheng, Mauro Orlando, Andrew X. Zhu & Takuji Okusaka. (2016) Second-line ramucirumab therapy for advanced hepatocellular carcinoma (REACH): an East Asian and non-East Asian subgroup analysis. Oncotarget 7:46, pages 75482-75491.
Crossref
Crossref
Woo Hyuck Choi, Hye Ryun Jo, Eun-Jeong Jeon, So-Young Youm, Jang Su Jeon, Yong-Gyu Son, Weon-Kyoo You, Woo Suk Koh, Sang Hoon Lee & Sang Kyum Kim. (2016) Development, validation, and application of ELISA for detection of anti-HD105 antibodies in pre-clinical safety evaluation using monkeys. Journal of Pharmaceutical and Biomedical Analysis 131, pages 309-315.
Crossref
Crossref
Roshank Ahani, Farzin Roohvand, Reza Ahangari Cohan, Mohammad Hossein Etemadzadeh, Nasir Mohajel, Mahdi Behdani, Zahra Shahosseini, Navid Madani & Kayhan Azadmanesh. (2016) Sindbis Virus-Pseudotyped Lentiviral Vectors Carrying VEGFR2-Specific Nanobody for Potential Transductional Targeting of Tumor Vasculature. Molecular Biotechnology 58:11, pages 738-747.
Crossref
Crossref
. 2016. Bio-Targets and Drug Delivery Approaches. Bio-Targets and Drug Delivery Approaches
233
252
.
Mythili Kameswaran, Usha Pandey, Naresh Gamre, K.V. Vimalnath, Haladhar Dev Sarma & Ashutosh Dash. (2016) Evaluation of 177Lu-CHX-A′′-DTPA-Bevacizumab as a radioimmunotherapy agent targeting VEGF expressing cancers. Applied Radiation and Isotopes 114, pages 196-201.
Crossref
Crossref
Laura Q. M. Chow, David C. Smith, Antoinette R. Tan, Crystal S. Denlinger, Ding Wang, Dale R. Shepard, Archana Chaudhary, Yong Lin & Ling Gao. (2016) Lack of pharmacokinetic drug?drug interaction between ramucirumab and paclitaxel in a phase II study of patients with advanced malignant solid tumors. Cancer Chemotherapy and Pharmacology 78:2, pages 433-441.
Crossref
Crossref
Yan-Da Lai, Yen-Yu Wu, Yi-Jiue Tsai, Yi-San Tsai, Yu-Ying Lin, Szu-Liang Lai, Chao-Yang Huang, Ying-Yung Lok, Chih-Yung Hu & Jiann-Shiun Lai. (2016) Generation of Potent Anti-Vascular Endothelial Growth Factor Neutralizing Antibodies from Mouse Phage Display Library for Cancer Therapy. International Journal of Molecular Sciences 17:2, pages 214.
Crossref
Crossref
Haiming Luo, Christopher G. England, Stephen A. Graves, Haiyan Sun, Glenn Liu, Robert J. Nickles & Weibo Cai. (2016)
PET Imaging of VEGFR-2 Expression in Lung Cancer with
64
Cu-Labeled Ramucirumab
. Journal of Nuclear Medicine 57:2, pages 285-290.
Crossref
Crossref
Shengdian Wang & Mingming Jia. 2016. Progress in Cancer Immunotherapy. Progress in Cancer Immunotherapy
1
67
.
Ali SalajeghehAli Salajegheh. 2016. Angiogenesis in Health, Disease and Malignancy. Angiogenesis in Health, Disease and Malignancy
363
374
.
Sara Massena, Gustaf Christoffersson, Evelina Vågesjö, Cédric Seignez, Karin Gustafsson, François Binet, Carmen Herrera Hidalgo, Antoine Giraud, Jalal Lomei, Simone Weström, Masabumi Shibuya, Lena Claesson-Welsh, Pär Gerwins, Michael Welsh, Johan Kreuger & Mia Phillipson. (2015) Identification and characterization of VEGF-A–responsive neutrophils expressing CD49d, VEGFR1, and CXCR4 in mice and humans. Blood 126:17, pages 2016-2026.
Crossref
Crossref
J.M. Redman, E.M. Hill, D. AlDeghaither & L.M. Weiner. (2015) Mechanisms of action of therapeutic antibodies for cancer. Molecular Immunology 67:2, pages 28-45.
Crossref
Crossref
Gamze Tan, Karsten Kantner, Qian Zhang, Mahmoud Soliman, Pablo del Pino, Wolfgang Parak, Mehmet Onur, Daniel Valdeperez, Joanna Rejman & Beatriz Pelaz. (2015) Conjugation of Polymer-Coated Gold Nanoparticles with Antibodies—Synthesis and Characterization. Nanomaterials 5:3, pages 1297-1316.
Crossref
Crossref
Chandrani Sarkar, Debanjan Chakroborty, Partha Sarathi Dasgupta & Sujit Basu. (2015) Dopamine is a safe antiangiogenic drug which can also prevent 5-fluorouracil induced neutropenia. International Journal of Cancer 137:3, pages 744-749.
Crossref
Crossref
Andrew X Zhu, Joon Oh Park, Baek-Yeol Ryoo, Chia-Jui Yen, Ronnie Poon, Davide Pastorelli, Jean-Frederic Blanc, Hyun Cheol Chung, Ari D Baron, Tulio Eduardo Flesch Pfiffer, Takuji Okusaka, Katerina Kubackova, Jorg Trojan, Javier Sastre, Ian Chau, Shao-Chun Chang, Paolo B Abada, Ling Yang, Jonathan D Schwartz & Masatoshi Kudo. (2015) Ramucirumab versus placebo as second-line treatment in patients with advanced hepatocellular carcinoma following first-line therapy with sorafenib (REACH): a randomised, double-blind, multicentre, phase 3 trial. The Lancet Oncology 16:7, pages 859-870.
Crossref
Crossref
S. Shirin Shahangian, Reza H. Sajedi, Sadegh Hasannia, Shirin Jalili, Mohammad Mohammadi, Majid Taghdir, Abbas Shali, Kamran Mansouri & Reyhaneh Sariri. (2015) A conformation-based phage-display panning to screen neutralizing anti-VEGF VHHs with VEGFR2 mimicry behavior. International Journal of Biological Macromolecules 77, pages 222-234.
Crossref
Crossref
Kristine M. Cornejo, April Deng, Hong Wu, Ediz F. Cosar, Ashraf Khan, Maryann St. Cyr, Keith Tomaszewicz, Karen Dresser, Patrick O’Donnell & Lloyd Hutchinson. (2015) The utility of MYC and FLT4 in the diagnosis and treatment of postradiation atypical vascular lesion and angiosarcoma of the breast. Human Pathology 46:6, pages 868-875.
Crossref
Crossref
Yasmine M. Abdel Aziz, Mohamed M. Said, Hosam A. El Shihawy & Khaled A.M. Abouzid. (2015) Discovery of novel tricyclic pyrido[3′,2′:4,5]thieno[3,2-d]pyrimidin-4-amine derivatives as VEGFR-2 inhibitors. Bioorganic Chemistry 60, pages 1-12.
Crossref
Crossref
Josep Tabernero, Takayuki Yoshino, Allen Lee Cohn, Radka Obermannova, Gyorgy Bodoky, Rocio Garcia-Carbonero, Tudor-Eliade Ciuleanu, David C Portnoy, Eric Van Cutsem, Axel Grothey, Jana Prausová, Pilar Garcia-Alfonso, Kentaro Yamazaki, Philip R Clingan, Sara Lonardi, Tae Won Kim, Lorinda Simms, Shao-Chun Chang & Federico Nasroulah. (2015) Ramucirumab versus placebo in combination with second-line FOLFIRI in patients with metastatic colorectal carcinoma that progressed during or after first-line therapy with bevacizumab, oxaliplatin, and a fluoropyrimidine (RAISE): a randomised, double-blind, multicentre, phase 3 study. The Lancet Oncology 16:5, pages 499-508.
Crossref
Crossref
Kai Lu & Sujit Basu. (2015) The natural compound chebulagic acid inhibits vascular endothelial growth factor A mediated regulation of endothelial cell functions. Scientific Reports 5:1.
Crossref
Crossref
Jacek R. Wilczyński & Marek Nowak. 2015. Cancer Immunology. Cancer Immunology
413
456
.
Filippa Fleetwood, Susanne Klint, Martin Hanze, Elin Gunneriusson, Fredrik Y. Frejd, Stefan Ståhl & John Löfblom. (2014) Simultaneous targeting of two ligand-binding sites on VEGFR2 using biparatopic Affibody molecules results in dramatically improved affinity. Scientific Reports 4:1.
Crossref
Crossref
Shravanti Mukherjee, Shilpi Saha, Argha Manna, Minakshi Mazumdar, Samik Chakraborty, Shrutarshi Paul & Tanya Das. (2014) Targeting Cancer Stem Cells by Phytochemicals: a Multimodal Approach to Colorectal Cancer. Current Colorectal Cancer Reports 10:4, pages 431-441.
Crossref
Crossref
Duarte Domingues, Alice Turner, Maria Dília Silva, Dânia Sofia Marques, Juan Carlos Mellidez, Luciano Wannesson, Giannis Mountzios & Ramon Andrade de Mello. (2014) Immunotherapy and lung cancer: current developments and novel targeted therapies. Immunotherapy 6:11, pages 1221-1235.
Crossref
Crossref
Jing Yang, Qun Wang, Chunxia Qiao, Zhou Lin, Xinying Li, Yifei Huang, Tingting Zhou, Yan Li, Beifen Shen, Ming Lv & Jiannan Feng. (2014) Potent anti-angiogenesis and anti-tumor activity of a novel human anti-VEGF antibody, MIL60. Cellular & Molecular Immunology 11:3, pages 285-293.
Crossref
Crossref
Zahra Farajpour, Fatemeh Rahbarizadeh, Bahram Kazemi, Davoud Ahmadvand & Mohammad Mohaghegh. (2014) Identification and In Vitro Characterization of Phage-Displayed VHHs Targeting VEGF. SLAS Discovery 19:4, pages 547-555.
Crossref
Crossref
Kenkichi Sugimoto, Suzuka Yoshida, Yuka Mashio, Naoka Toyota, Yanjiang Xing, Henan Xu, Yuki Fujita, Zhijun Huang, Maki Touma & Qiong Wu. (2014) Role of FGF10 on tumorigenesis by MS-K. Genes to Cells 19:2, pages 112-125.
Crossref
Crossref
Epie Boven & Gert Jan Ossenkoppele. 2014. Ontwikkelingen in de oncologie. Ontwikkelingen in de oncologie
55
66
.
Roberto García-Figueiras & Anwar R. Padhani. 2014. Functional Imaging in Oncology. Functional Imaging in Oncology
77
96
.
Hadi A. Goubran, Thierry Burnouf, Mirjana Radosevic & Magdy El-Ekiaby. (2013) The platelet?cancer loop. European Journal of Internal Medicine 24:5, pages 393-400.
Crossref
Crossref
Masahiro Toda. (2013) Glioma Stem Cells and Immunotherapy for the Treatment of Malignant Gliomas. ISRN Oncology 2013, pages 1-13.
Crossref
Crossref
David Xu & Peter K Kaiser. (2013) Intravitreal aflibercept for neovascular age-related macular degeneration. Immunotherapy 5:2, pages 121-130.
Crossref
Crossref
De-Chun Li. (2012) Lentivirus-mediated shRNA interference targeting vascular endothelial growth factor inhibits angiogenesis and progression of human pancreatic carcinoma. Oncology Reports.
Crossref
Crossref
Flavia R.S. Lima, Suzana Assad Kahn, Rossana C. Soletti, Deborah Biasoli, Tercia Alves, Anna Carolina C. da Fonseca, Celina Garcia, Luciana Romão, José Brito, Rosenilde Holanda-Afonso, Jane Faria, Helena Borges & Vivaldo Moura-Neto. (2012) Glioblastoma: Therapeutic challenges, what lies ahead. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1826:2, pages 338-349.
Crossref
Crossref
Hebah H. Al-Habboubi, Najat Mahdi, Tala M. Abu-Hijleh, Farah M. Abu-Hijleh, Mai S. Sater & Wassim Y. Almawi. (2012) The relation of vascular endothelial growth factor (VEGF) gene polymorphisms on VEGF levels and the risk of vasoocclusive crisis in sickle cell disease. European Journal of Haematology 89:5, pages 403-409.
Crossref
Crossref
Harold J. Wanebo, Mark LeGolvan, Philip B. Paty, Sukamal Saha, Markus Zuber, Michael I. D?Angelica & Nancey E. Kemeny. (2012) Meeting the biologic challenge of colorectal metastases. Clinical & Experimental Metastasis 29:7, pages 821-839.
Crossref
Crossref
Janice M. Reichert & Eugen Dhimolea. (2012) The future of antibodies as cancer drugs. Drug Discovery Today 17:17-18, pages 954-963.
Crossref
Crossref
Natalia Davydova, Victor A. Streltsov, Sally Roufail, George O. Lovrecz, Steven A. Stacker, Timothy E. Adams & Marc G. Achen. (2012) Preparation of human vascular endothelial growth factor-D for structural and preclinical therapeutic studies. Protein Expression and Purification 82:1, pages 232-239.
Crossref
Crossref
Jun-ye XIONG, Xiao-yan KANG & Zheng-feng YIN. (2011) Glycosaminoglycans-binding cytokines and tumor. Academic Journal of Second Military Medical University 31:8, pages 898-901.
Crossref
Crossref
Roberto García Figueiras, Anwar R. Padhani, Vicky J. Goh, Joan C. Vilanova, Sandra Baleato González, Carmen Villalba Martín, Antonio Gómez Caamaño, Anaberta Bermúdez Naveira & Peter L. Choyke. (2011) Novel Oncologic Drugs: What They Do and How They Affect Images. RadioGraphics 31:7, pages 2059-2091.
Crossref
Crossref
E. Boven & G.J. Ossenkoppele. (2012) Targeted therapieën tegen kanker. Huisarts en wetenschap 54:5, pages 266-271.
Crossref
Crossref
Frederico Pittella, Mingzhen Zhang, Yan Lee, Hyun J. Kim, Theofilus Tockary, Kensuke Osada, Takehiko Ishii, Kanjiro Miyata, Nobuhiro Nishiyama & Kazunori Kataoka. (2011) Enhanced endosomal escape of siRNA-incorporating hybrid nanoparticles from calcium phosphate and PEG-block charge-conversional polymer for efficient gene knockdown with negligible cytotoxicity. Biomaterials 32:11, pages 3106-3114.
Crossref
Crossref
A. Salajegheh, R.A. Smith, K. Kasem, V. Gopalan, M.R. Nassiri, R. William & A.K.Y. Lam. (2011) Single nucleotide polymorphisms and mRNA expression of VEGF-A in papillary thyroid carcinoma: Potential markers for aggressive phenotypes. European Journal of Surgical Oncology (EJSO) 37:1, pages 93-99.
Crossref
Crossref
Mark P. LeGolvan & Murray Resnick. (2010) Pathobiology of colorectal cancer hepatic metastases with an emphasis on prognostic factors. Journal of Surgical Oncology 102:8, pages 898-908.
Crossref
Crossref
Jacek R. Wilczyński & Markus Duechler. (2010) How do Tumors Actively Escape from Host Immunosurveillance?. Archivum Immunologiae et Therapiae Experimentalis 58:6, pages 435-448.
Crossref
Crossref